Showing results (861-870 of 3,351) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|January 22, 2005
Are the economics of pharmaceutical research and development changing?: productivity, patents and political pressuresHenry GrabowskiPharmacoeconomics|January 22, 2005
The effects of pharmaceutical consumption and obesity on the quality of life in the organization of economic cooperation and development (OECD) countriesH E Frech, Richard D MillerPharmacoeconomics|January 22, 2005
The role of pharmacoepidemiology and pharmacoeconomics in promoting access and stimulating innovationJerry AvornPharmacoeconomics|November 5, 2003
Costs and cost effectiveness of low molecular weight heparins and platelet glycoprotein IIb/IIIa inhibitors: in the management of acute coronary syndromesNick Bosanquet, Bengt Jönsson, Keith A A FoxPharmacoeconomics|January 15, 2004
Assessing the value of antipsychotics for treating schizophrenia: the importance of evaluating and interpreting the clinical significance of individual service costsSandra L Tunis, Haya Ascher-Svanum, Michael Stensland, et al.Pharmacoeconomics|January 15, 2004
Why did drug spending increase during the 1990s? A decomposition based on Swedish dataUlf-G Gerdtham, Douglas LundinPharmacoeconomics|January 15, 2004
A multicentre study of patient survival, disability, quality of life and cost of care: among patients with AIDS in northern ItalyAndrea Tramarin, Stefano Campostrini, Maarten J Postma, et al.Pharmacoeconomics|January 15, 2004
Allocation of resources between smoking cessation methods and lovastatin treatment of hypercholesterolaemia: based on cost effectiveness and the social welfare functionPedro Plans-RubióPharmacoeconomics|June 26, 2004
The role of cost-effectiveness analysis in the era of pharmacogenomicsChristopher R Flowers, David VeenstraPageof 336